Johnson & Johnson made a tough call recently. They stopped a mid-stage trial for a new eczema drug. The drug, JNJ-5939, was supposed to help people with moderate to severe eczema. But it didn't work as well as hoped. The trial showed that the drug was safe to use. People didn't have bad reactions t
Johnson Matthey, a big name in the chemical industry, has some big changes happening at the top. Richard Pike, who was the finance chief, is now the new Chief Operating Officer. This means he will be in charge of making sure the company runs smoothly every day. At the same time, Alastair Judge, who
Speaker verification (SV) systems are usually heavy on storage and computing power, making them tough to use on mobile devices. This is where adaptive neural network quantization comes in. Imagine a novel method that allows each layer of the network to have its own unique quantization centroids, gen
